{"id":"labetalol-nifedipine","safety":{"commonSideEffects":[{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Bradycardia"},{"rate":null,"effect":"Flushing"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Labetalol blocks alpha-1, beta-1, and beta-2 adrenergic receptors, reducing heart rate and contractility while causing vasodilation. Nifedipine blocks L-type calcium channels in vascular smooth muscle, causing direct vasodilation. Together, they provide complementary antihypertensive effects with potentially synergistic blood pressure reduction.","oneSentence":"This combination of a non-selective beta-blocker (labetalol) and a calcium channel blocker (nifedipine) reduces blood pressure through dual inhibition of cardiac contractility and vascular smooth muscle contraction.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:49:12.144Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension management in pregnancy or hypertensive emergency (Phase 3 context suggests maternal/obstetric indication)"}]},"trialDetails":[{"nctId":"NCT03511118","phase":"","title":"Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants","status":"RECRUITING","sponsor":"Duke University","startDate":"2018-10-04","conditions":"Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI","enrollment":1600},{"nctId":"NCT05551104","phase":"PHASE3","title":"Safest Choice of Antihypertensive Regimen for Postpartum Hypertension","status":"RECRUITING","sponsor":"Loma Linda University","startDate":"2023-05-08","conditions":"Postpartum Complication, Maternal Hypertension, High Blood Pressure","enrollment":500},{"nctId":"NCT07363343","phase":"NA","title":"Nifedipine and Enalapril vs Nifedipine and Labetalol for the Treatment of Postpartum Hypertension Study","status":"NOT_YET_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2026-02-01","conditions":"Hypertension, Postpartum Preeclampsia","enrollment":200},{"nctId":"NCT04298034","phase":"PHASE3","title":"Preeclampsia Postpartum Antihypertensive Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2020-07-17","conditions":"Preeclampsia, Hypertension in Pregnancy","enrollment":300},{"nctId":"NCT05989581","phase":"PHASE1","title":"Chronic Hypertension and Pregnancy 2 (CHAP2) Pilot Project","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2024-04-24","conditions":"Hypertension in Pregnancy","enrollment":74},{"nctId":"NCT04755764","phase":"","title":"Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy","status":"RECRUITING","sponsor":"Marshall University","startDate":"2021-03-03","conditions":"Systolic Hypertension, Pregnancy Related, Diastolic Hypertension","enrollment":60},{"nctId":"NCT06915792","phase":"PHASE4","title":"PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy","status":"NOT_YET_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2025-04-01","conditions":"Postpartum Hypertension (PPHT)","enrollment":110},{"nctId":"NCT05139238","phase":"PHASE4","title":"Postpartum Hypertension Study","status":"RECRUITING","sponsor":"Columbia University","startDate":"2022-07-04","conditions":"Postpartum Pregnancy-Induced Hypertension, Postpartum Preeclampsia, Pregnancy-Induced Hypertension in Postpartum","enrollment":104},{"nctId":"NCT04278404","phase":"","title":"Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)","status":"RECRUITING","sponsor":"Duke University","startDate":"2020-03-05","conditions":"Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension, Urinary Tract Infections in Children","enrollment":5000},{"nctId":"NCT05955040","phase":"PHASE2","title":"Treatment of Elevated Blood Pressures in Early Pregnancy","status":"TERMINATED","sponsor":"Marshall University","startDate":"2023-07-11","conditions":"Elevated Blood Pressure, Pregnancy Induced Hypertension","enrollment":2},{"nctId":"NCT05309460","phase":"PHASE4","title":"Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial","status":"RECRUITING","sponsor":"Nebraska Methodist Health System","startDate":"2022-06-20","conditions":"Postpartum Preeclampsia, Hypertension in Pregnancy","enrollment":600},{"nctId":"NCT06265415","phase":"NA","title":"Comparative Study of Intravenous Labetalol Versus Intravenous Nitroglycerin Versus Sublingual Nifedipine","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2024-03-30","conditions":"Severe Preeclampsia","enrollment":60},{"nctId":"NCT01431326","phase":"","title":"Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care","status":"COMPLETED","sponsor":"Daniel Benjamin","startDate":"2011-11","conditions":"Adenovirus, Anesthesia, Anxiety","enrollment":3520},{"nctId":"NCT02299414","phase":"PHASE4","title":"Chronic Hypertension and Pregnancy (CHAP) Project","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2015-06","conditions":"Hypertension","enrollment":2408},{"nctId":"NCT05670028","phase":"PHASE2","title":"Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-06-04","conditions":"Ischemic Stroke, Revascularization, Blood Pressure","enrollment":100},{"nctId":"NCT03506724","phase":"PHASE4","title":"Response to Anti-hypertensives in Pregnant and Postpartum Patients","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2017-09-11","conditions":"Hypertension in Pregnancy, Preeclampsia","enrollment":109},{"nctId":"NCT04467931","phase":"","title":"ACEI or ARB and COVID-19 Severity and Mortality in US Veterans","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-01-19","conditions":"Hypertension, COVID","enrollment":22213},{"nctId":"NCT02531490","phase":"PHASE4","title":"Early Vascular Adjustments During Hypertensive Pregnancy","status":"UNKNOWN","sponsor":"Maastricht University Medical Center","startDate":"2015-01-01","conditions":"Hypertension, Pregnancy-Induced, Pre-Eclampsia","enrollment":368},{"nctId":"NCT03245970","phase":"EARLY_PHASE1","title":"Impedance Cardiography to Decrease the Risk of Preeclampsia","status":"WITHDRAWN","sponsor":"University of Tennessee Medical Center","startDate":"2017-04-24","conditions":"Chronic Hypertension Complicating Pregnancy (Diagnosis), Preeclampsia","enrollment":""},{"nctId":"NCT04216706","phase":"","title":"Early Vascular Adjustments to Prevent Preeclampsia","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2014-11-01","conditions":"Preeclampsia, Small for Gestational Age at Delivery, HELLP Syndrome","enrollment":314},{"nctId":"NCT03105661","phase":"EARLY_PHASE1","title":"Use of Impedance Cardiography to Decrease the Risk of Pre-eclampsia in Obese Patients","status":"UNKNOWN","sponsor":"University of Tennessee Graduate School of Medicine","startDate":"2017-04-04","conditions":"Obesity, Morbid, Preeclampsia","enrollment":400},{"nctId":"NCT01912677","phase":"PHASE4","title":"Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2015-04","conditions":"Hypertension in Pregnancy, Preeclampsia","enrollment":894},{"nctId":"NCT03449277","phase":"PHASE4","title":"Oral Nifedipine Versus Labetalol in Treatment of Postpartum Hypertension","status":"UNKNOWN","sponsor":"Hossam Ahmed Abd Ellah","startDate":"2018-01-19","conditions":"Postpartum Preeclampsia","enrollment":100},{"nctId":"NCT02168309","phase":"NA","title":"Oral Nifedipine Versus Oral Labetalol","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2014-06","conditions":"Severe Postpartum Hypertension","enrollment":50},{"nctId":"NCT02912910","phase":"","title":"Changes in Central Arterial Pressure When Comparing Nifedipine/Labetalol for Routine Hypertension Control in Pregnancy","status":"WITHDRAWN","sponsor":"St. Louis University","startDate":"2016-09","conditions":"Hypertension","enrollment":""},{"nctId":"NCT02933593","phase":"NA","title":"Changes in Central Arterial Pressure When Comparing ACOG Hypertensive Urgency Protocols","status":"WITHDRAWN","sponsor":"St. Louis University","startDate":"2016-08","conditions":"Hypertension","enrollment":""},{"nctId":"NCT03325348","phase":"PHASE2, PHASE3","title":"Oral Nifedipine Versus IV Labetalol in Severe Pre Eclampsia","status":"UNKNOWN","sponsor":"Services Institute of Medical Sciences, Pakistan","startDate":"2017-02-23","conditions":"Severe Pre-Eclampsia, Antepartum","enrollment":194},{"nctId":"NCT00194974","phase":"PHASE1, PHASE2","title":"Treatment Targets for Chronic Hypertension in Pregnancy","status":"WITHDRAWN","sponsor":"Weill Medical College of Cornell University","startDate":"2004-07","conditions":"Pregnancy Toxemia, Hypertension, Proteinuria","enrollment":""},{"nctId":"NCT02426177","phase":"PHASE3","title":"Comparison of Tab.Labetalol and Tab.Nifedipine for Management of Postpartum Hypertension","status":"UNKNOWN","sponsor":"Dow University of Health Sciences","startDate":"2015-05","conditions":"Postnatal Hypertension","enrollment":98},{"nctId":"NCT00684489","phase":"NA","title":"Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2003-09","conditions":"Hypertension","enrollment":52}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":266,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Procardia","Trandate, Normodyne"],"phase":"phase_3","status":"active","brandName":"Labetalol, Nifedipine","genericName":"Labetalol, Nifedipine","companyName":"Medical College of Wisconsin","companyId":"medical-college-of-wisconsin","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination of a non-selective beta-blocker (labetalol) and a calcium channel blocker (nifedipine) reduces blood pressure through dual inhibition of cardiac contractility and vascular smooth muscle contraction. Used for Hypertension management in pregnancy or hypertensive emergency (Phase 3 context suggests maternal/obstetric indication).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}